Selected research
Industry Research
Neprilysin Industry Research Report 2026
Market perspective
The global Neprilysin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Neprilysin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Neprilysin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Neprilysin include Novartis AG, Theravance Biopharma Inc, Pharmaleads SA and Bioprojet SCR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Neprilysin market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neprilysin Market by Company
Novartis AG
Theravance Biopharma Inc
Pharmaleads SA
Bioprojet SCR
Neprilysin Segment by Type
TD-0714
STR-324
PL-265
LHW-090
Others
Neprilysin Segment by Application
Acute Heart Failure
Hypertension
Cancer Pain
Alzheimer's Disease
Others
Neprilysin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neprilysin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neprilysin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neprilysin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Neprilysin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Neprilysin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Neprilysin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- TD-0714
- STR-324
- PL-265
- LHW-090
- Others
Applications
- Acute Heart Failure
- Hypertension
- Cancer Pain
- Alzheimer's Disease
- Others
Companies covered
- Novartis AG
- Theravance Biopharma Inc
- Pharmaleads SA
- Bioprojet SCR
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Neprilysin Market Size (2021-2032)
- 2.2.2 Global Neprilysin Sales (2021-2032)
- 2.2.3 Global Neprilysin Market Average Price (2021-2032)
- 2.3 Neprilysin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 TD-0714
- 2.3.3 STR-324
- 2.3.4 PL-265
- 2.3.5 LHW-090
- 2.3.6 Others
- 2.4 Neprilysin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Acute Heart Failure
- 2.4.3 Hypertension
- 2.4.4 Cancer Pain
- 2.4.5 Alzheimer's Disease
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Neprilysin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Neprilysin Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Neprilysin Revenue of Manufacturers (2021-2026)
- 3.4 Global Neprilysin Average Price by Manufacturers (2021-2026)
- 3.5 Global Neprilysin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Neprilysin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Neprilysin, Product Type & Application
- 3.8 Global Manufacturers of Neprilysin, Established Date
- 3.9 Global Neprilysin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis AG
- 4.1.1 Novartis AG Company Information
- 4.1.2 Novartis AG Business Overview
- 4.1.3 Novartis AG Neprilysin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis AG Neprilysin Product Portfolio
- 4.1.5 Novartis AG Recent Developments
- 4.2 Theravance Biopharma Inc
- 4.2.1 Theravance Biopharma Inc Company Information
- 4.2.2 Theravance Biopharma Inc Business Overview
- 4.2.3 Theravance Biopharma Inc Neprilysin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Theravance Biopharma Inc Neprilysin Product Portfolio
- 4.2.5 Theravance Biopharma Inc Recent Developments
- 4.3 Pharmaleads SA
- 4.3.1 Pharmaleads SA Company Information
- 4.3.2 Pharmaleads SA Business Overview
- 4.3.3 Pharmaleads SA Neprilysin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pharmaleads SA Neprilysin Product Portfolio
- 4.3.5 Pharmaleads SA Recent Developments
- 4.4 Bioprojet SCR
- 4.4.1 Bioprojet SCR Company Information
- 4.4.2 Bioprojet SCR Business Overview
- 4.4.3 Bioprojet SCR Neprilysin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bioprojet SCR Neprilysin Product Portfolio
- 4.4.5 Bioprojet SCR Recent Developments
5 Global Neprilysin Market Scenario by Region
- 5.1 Global Neprilysin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Neprilysin Sales by Region: 2021-2032
- 5.2.1 Global Neprilysin Sales by Region: 2021-2026
- 5.2.2 Global Neprilysin Sales by Region: 2027-2032
- 5.3 Global Neprilysin Revenue by Region: 2021-2032
- 5.3.1 Global Neprilysin Revenue by Region: 2021-2026
- 5.3.2 Global Neprilysin Revenue by Region: 2027-2032
- 5.4 North America Neprilysin Market Facts & Figures by Country
- 5.4.1 North America Neprilysin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Neprilysin Sales by Country (2021-2032)
- 5.4.3 North America Neprilysin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Neprilysin Market Facts & Figures by Country
- 5.5.1 Europe Neprilysin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Neprilysin Sales by Country (2021-2032)
- 5.5.3 Europe Neprilysin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Neprilysin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Neprilysin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Neprilysin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Neprilysin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Neprilysin Market Facts & Figures by Country
- 5.7.1 South America Neprilysin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Neprilysin Sales by Country (2021-2032)
- 5.7.3 South America Neprilysin Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Neprilysin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Neprilysin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Neprilysin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Neprilysin Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Neprilysin Sales by Type (2021-2032)
- 6.1.1 Global Neprilysin Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Neprilysin Sales Market Share by Type (2021-2032)
- 6.2 Global Neprilysin Revenue by Type (2021-2032)
- 6.2.1 Global Neprilysin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Neprilysin Revenue Market Share by Type (2021-2032)
- 6.3 Global Neprilysin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Neprilysin Sales by Application (2021-2032)
- 7.1.1 Global Neprilysin Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Neprilysin Sales Market Share by Application (2021-2032)
- 7.2 Global Neprilysin Revenue by Application (2021-2032)
- 7.2.1 Global Neprilysin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Neprilysin Revenue Market Share by Application (2021-2032)
- 7.3 Global Neprilysin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Neprilysin Value Chain Analysis
- 8.1.1 Neprilysin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Neprilysin Production Mode & Process
- 8.2 Neprilysin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Neprilysin Distributors
- 8.2.3 Neprilysin Customers
9 Global Neprilysin Analyzing Market Dynamics
- 9.1 Neprilysin Industry Trends
- 9.2 Neprilysin Industry Drivers
- 9.3 Neprilysin Industry Opportunities and Challenges
- 9.4 Neprilysin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst